IL22 and inflammatory bowel disease: To assess the inflammatory responses, our primary focus was on pro-inflammatory cytokines TNF-alpha and IL-22 due to their high impact on disease onset and progression in experimental colitis [37, 38], role in exacerbating inflammation in IBD (TNF-alpha) [39], and importance in intestinal wound healing and prevention of tissue damage in IBD (Il-22) [40].